Change in Aiforia Technologies Plc’s Management Team
Aiforia Technologies Plc, Company release, 24 November 2022 at 08:00 a.m. EEST. Kari Pitkänen, Director of Business Development at Aiforia Technologies Plc, will retire by the end of December 2022.
Kari is one of the founders of the company and has been a member of the Management Team since 2013. After his retirement, he will continue as a member of Aiforia’s Advisory Board.
“I would like to warmly thank Kari for his significant contribution in building Aiforia from a startup to an internationally operating listed company. His fantastic career is all about developing global businesses in the fields of biotechnology and health technology. I am pleased to know that Kari will join our Advisory Board, giving us the opportunity to keep working together and to count on his support,” says Jukka Tapaninen, CEO of Aiforia Technologies Plc.
As of 1 January 2023, the composition of Aiforia’s Management Team is as follows:
Jukka Tapaninen, Chief Executive Officer
Kaisa Helminen, Chief Operating Officer
Veli-Matti Parkkonen, Chief Financial Officer
Tuomas Ropponen, Chief Technology Officer
Thomas Westerling-Bui, Chief Commercial Officer, Americas
More detailed information on the members of the Management Team is available on the company's website at https://investors.aiforia.com/management-team.
Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc, tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Securities Ltd, tel. +358 9 25 380 225
About Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more. Find out more at www.aiforia.com
